Product

Cellavita HD

Aliases

cellular therapy, mesenchymal stem cells

2 clinical trials

1 indication

Indication

Huntington's disease

Clinical trial

Dose-Response Evaluation of the Investigational Product Cellavita HD After Intravenous Administration in Patients With Huntington's Disease

Status: Completed, Estimated PCD: 2021-03-23

Clinical trial

First in Human Study to Evaluate Safety of Cellavita HD Investigational Product After Intravenous Application in Participants With Huntington's Disease

Status: Active (not recruiting), Estimated PCD: 2022-12-31